A detailed history of Baker Avenue Asset Management, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 15,809 shares of LLY stock, worth $12.5 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
15,809
Previous 12,499 26.48%
Holding current value
$12.5 Million
Previous $11.3 Million 23.76%
% of portfolio
0.41%
Previous 0.32%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$772.14 - $960.02 $2.56 Million - $3.18 Million
3,310 Added 26.48%
15,809 $14 Million
Q2 2024

Aug 07, 2024

SELL
$724.87 - $909.04 $199,339 - $249,986
-275 Reduced 2.15%
12,499 $11.3 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $159,301 - $213,123
269 Added 2.15%
12,774 $9.94 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $425,403 - $501,495
810 Added 6.93%
12,505 $7.29 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $4.1 Million - $5.65 Million
9,430 Added 416.34%
11,695 $6.28 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $421,589 - $563,713
1,202 Added 113.08%
2,265 $1.06 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $369,339 - $433,770
-1,189 Reduced 52.8%
1,063 $365,000
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $39,872 - $46,459
-124 Reduced 5.22%
2,252 $823,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $330,871 - $377,062
1,116 Added 88.57%
2,376 $768,000
Q2 2022

Aug 03, 2022

SELL
$278.73 - $327.27 $25,643 - $30,108
-92 Reduced 6.8%
1,260 $408,000
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $148,558 - $184,620
-633 Reduced 31.89%
1,352 $387,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $174,483 - $216,535
776 Added 64.19%
1,985 $548,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $7,312 - $8,999
33 Added 2.81%
1,209 $279,000
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $7,402 - $9,575
41 Added 3.61%
1,176 $269,000
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $186,503 - $241,437
1,135 New
1,135 $212,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.